Urine Drug Screening Requirement

L3 decorative image

The University of Pittsburgh School of Nursing adheres to mandatory urine drug screening for students in clinical rotations to comply with regulations set by our clinical partners, Allegheny Health Network (AHN) and UPMC.

Effective Fall 2023, all students must submit a urine drug screening before the start of their clinical term.

The UPMC urine drug screen is required for all students before the start of clinical rotations. Once completed, it is valid for the duration of the student's clinical education. Those drugs to be included in the 5-panel drug screening are:

  • amphetamines
  • cocaine
  • marijuana
  • opiates
  • Phencyclidine (PCP) *Please be sure your screening includes PCP, often standard 5-Panel screens exclude this drug

If a student is assigned to an AHN or alternate facility, the Clinical Management Office (CMO) will notify the student to undergo an additional 9-panel drug test. This screening is time sensitive and must be completed within 30 days of the clinical rotation start date. Those drugs to be included in the 9-Panel drug screening are:

  • cocaine
  • opiates
  • amphetamine
  • barbiturates
  • oxycodone
  • benzodiazepines
  • methamphetamine
  • methadone
  • phencyclidine (PCP)
    *Please be sure your screening includes PCP, often standard 9-Panel screens exclude this drug

Students are responsible for the cost of their drug tests. These requirements are mandatory and were established by each medical facility. If a urine drug test yields positive results, the clinical agency will conduct a further evaluation.

For more information, please refer to the frequently asked questions (FAQ) below.
Any additional questions may be directed to Clinical Management Office at CMONursing@pitt.edu.